Cellect Biotechnology, Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology, Ltd., a foreign private issuer, on September 20, 2021. The report covers the month of September 2021 and pertains to a corporate governance event regarding a Special General Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a shareholder meeting status and does not contain financial statements or performance data.
Material Changes
The primary material event reported is the adjournment of the Special General Meeting of Shareholders originally convened on September 19, 2021. The meeting was adjourned for one week due to a lack of a quorum.
Outlook and Management Commentary
Management has scheduled the reconvened Special General Meeting for Sunday, September 26, 2021, at 11:00 a.m. Israel time. The meeting will be held at the offices of the Company's legal counsel, Doron, Tikotzky, Kantor, Gutman, Nass, Amit Gross & Co., located at B.S.R. 4 Tower, 33rd Floor, 7 Metsada Street, Bnei Brak. No specific business outlook, risks, or unusual items were detailed in this filing.
Key Facts for Investor Verification
- The Special General Meeting of Shareholders was adjourned on September 19, 2021, due to insufficient attendance (lack of quorum).
- The meeting is rescheduled for September 26, 2021, at 11:00 a.m. Israel time.
- The location for the reconvened meeting is the legal counsel's offices in Bnei Brak, Israel.
- This filing contains no financial performance data or updated guidance.